Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheldon Spector

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Data in Brief|September 23, 2016
Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthmaVeit J Erpenbeck, Todor A Popov, David Miller, et al.
Pulmonary Pharmacology & Therapeutics|June 30, 2016
The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthmaVeit J Erpenbeck, Todor A Popov, David Miller, et al.
The Journal of Investigative Dermatology|July 22, 2014
Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled studySarbjit S Saini, Carsten Bindslev-Jensen, Marcus Maurer, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 13, 2015
Contact dermatitis: a practice parameter-update 2015Luz Fonacier, David I Bernstein, Karin Pacheco, et al.
The New England Journal of Medicine|May 22, 2013
Dupilumab in persistent asthma with elevated eosinophil levelsSally Wenzel, Linda Ford, David Pearlman, et al.
The Journal of Allergy and Clinical Immunology|February 5, 2013
Atopic dermatitis: a practice parameter update 2012Lynda Schneider, Stephen Tilles, Peter Lio, et al.
The Journal of Allergy and Clinical Immunology|August 14, 2013
Environmental assessment and exposure reduction of cockroaches: a practice parameterJay Portnoy, Ginger L Chew, Wanda Phipatanakul, et al.
The Journal of Allergy and Clinical Immunology|September 2, 2014
Food allergy: a practice parameter update-2014Hugh A Sampson, Seema Aceves, S Allan Bock, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Data in Brief|September 23, 2016
Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthmaVeit J Erpenbeck, Todor A Popov, David Miller, et al.
Pulmonary Pharmacology & Therapeutics|June 30, 2016
The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthmaVeit J Erpenbeck, Todor A Popov, David Miller, et al.
The Journal of Investigative Dermatology|July 22, 2014
Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled studySarbjit S Saini, Carsten Bindslev-Jensen, Marcus Maurer, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 13, 2015
Contact dermatitis: a practice parameter-update 2015Luz Fonacier, David I Bernstein, Karin Pacheco, et al.
The New England Journal of Medicine|May 22, 2013
Dupilumab in persistent asthma with elevated eosinophil levelsSally Wenzel, Linda Ford, David Pearlman, et al.
The Journal of Allergy and Clinical Immunology|February 5, 2013
Atopic dermatitis: a practice parameter update 2012Lynda Schneider, Stephen Tilles, Peter Lio, et al.
The Journal of Allergy and Clinical Immunology|August 14, 2013
Environmental assessment and exposure reduction of cockroaches: a practice parameterJay Portnoy, Ginger L Chew, Wanda Phipatanakul, et al.
The Journal of Allergy and Clinical Immunology|September 2, 2014
Food allergy: a practice parameter update-2014Hugh A Sampson, Seema Aceves, S Allan Bock, et al.
Pageof 2